Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Camille Buffet

Showing results (61-70 of 84) with videos related to

Pageof 9
Sort By:
Thyroid : Official Journal of the American Thyroid Association|July 26, 2022
Possible Primary Thyroid Nuclear Protein in Testis Carcinomas with <i>NSD3::NUTM1</i> Translocation Revealed by RNA Sequencing: A Report of Two CasesNoémie Scherman, Johanna Wassermann, Camille Tlemsani, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|March 9, 2026
Enhancing patient selection for thyroid thermal ablation: insights from a multidisciplinary team approachSylvie Daclin, Gilles Russ, Sylvain Poiree, et al.
European Journal of Endocrinology|July 28, 2022
Detection of BRAFV600E by digital PCR on fine-needle aspirate enables rapid initiation of dabrafenib and trametinib in unresectable anaplastic thyroid carcinomaCamille Buffet, Lucie Allard, Erell Guillerm, et al.
Annales D'Endocrinologie|April 27, 2025
ENDOCAN-TUTHYREF network consensus recommendations. Refractory medullary thyroid cancerHélène Lasolle, Christine Do Cao, Livia Lamartina, et al.
Bulletin Du Cancer|October 1, 2021
[Molecular genotyping in refractory thyroid cancers in 2021: When, how and why? A review from the TUTHYREF network]Christelle de la Fouchardière, Johanna Wassermann, Fabien Calcagno, et al.
Thyroid : Official Journal of the American Thyroid Association|June 10, 2023
Dysfunction of the Salivary and Lacrimal Glands After Radioiodine Therapy for Thyroid Cancer: Results of the START Study After 6-Months of Follow-UpClémence Baudin, Alice Bressand, Camille Buffet, et al.
Frontiers in Immunology|April 25, 2020
Tissue Infiltrating LTi-Like Group 3 Innate Lymphoid Cells and T Follicular Helper Cells in Graves' and Hashimoto's ThyroiditisAudrey Mohr, Christophe Trésallet, Natacha Monot, et al.
Annales D'Endocrinologie|May 9, 2025
ENDOCAN TUTHYREF network consensus recommendations: Refractory follicular-derived thyroid cancerChristine Do Cao, Yann Godbert, Stéphane Bardet, et al.
The Lancet. Diabetes & Endocrinology|May 30, 2018
Outcome after ablation in patients with low-risk thyroid cancer (ESTIMABL1): 5-year follow-up results of a randomised, phase 3, equivalence trialMartin Schlumberger, Sophie Leboulleux, Bogdan Catargi, et al.
International Journal of Biological Sciences|February 16, 2026
NOX4-derived oxidative DNA damage impairs thyroid differentiation through an epigenetic mechanism in BRAF-mutated radioactive iodine refractory papillary thyroid cancer cellsMickaëlle Radom, Camille Buffet, Juliana Cazarin, et al.
Pageof 9

Showing results (61-70 of 84) with videos related to

Sort By:
Pageof 9
Thyroid : Official Journal of the American Thyroid Association|July 26, 2022
Possible Primary Thyroid Nuclear Protein in Testis Carcinomas with <i>NSD3::NUTM1</i> Translocation Revealed by RNA Sequencing: A Report of Two CasesNoémie Scherman, Johanna Wassermann, Camille Tlemsani, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|March 9, 2026
Enhancing patient selection for thyroid thermal ablation: insights from a multidisciplinary team approachSylvie Daclin, Gilles Russ, Sylvain Poiree, et al.
European Journal of Endocrinology|July 28, 2022
Detection of BRAFV600E by digital PCR on fine-needle aspirate enables rapid initiation of dabrafenib and trametinib in unresectable anaplastic thyroid carcinomaCamille Buffet, Lucie Allard, Erell Guillerm, et al.
Annales D'Endocrinologie|April 27, 2025
ENDOCAN-TUTHYREF network consensus recommendations. Refractory medullary thyroid cancerHélène Lasolle, Christine Do Cao, Livia Lamartina, et al.
Bulletin Du Cancer|October 1, 2021
[Molecular genotyping in refractory thyroid cancers in 2021: When, how and why? A review from the TUTHYREF network]Christelle de la Fouchardière, Johanna Wassermann, Fabien Calcagno, et al.
Thyroid : Official Journal of the American Thyroid Association|June 10, 2023
Dysfunction of the Salivary and Lacrimal Glands After Radioiodine Therapy for Thyroid Cancer: Results of the START Study After 6-Months of Follow-UpClémence Baudin, Alice Bressand, Camille Buffet, et al.
Frontiers in Immunology|April 25, 2020
Tissue Infiltrating LTi-Like Group 3 Innate Lymphoid Cells and T Follicular Helper Cells in Graves' and Hashimoto's ThyroiditisAudrey Mohr, Christophe Trésallet, Natacha Monot, et al.
Annales D'Endocrinologie|May 9, 2025
ENDOCAN TUTHYREF network consensus recommendations: Refractory follicular-derived thyroid cancerChristine Do Cao, Yann Godbert, Stéphane Bardet, et al.
The Lancet. Diabetes & Endocrinology|May 30, 2018
Outcome after ablation in patients with low-risk thyroid cancer (ESTIMABL1): 5-year follow-up results of a randomised, phase 3, equivalence trialMartin Schlumberger, Sophie Leboulleux, Bogdan Catargi, et al.
International Journal of Biological Sciences|February 16, 2026
NOX4-derived oxidative DNA damage impairs thyroid differentiation through an epigenetic mechanism in BRAF-mutated radioactive iodine refractory papillary thyroid cancer cellsMickaëlle Radom, Camille Buffet, Juliana Cazarin, et al.
Pageof 9